Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1169 | Male Reproduction | ECE2017

Can salivary testosterone be used in the monitoring of men using transdermal testosterone replacement therapy?

Ahern Tomas , Adaway Jo , Monaghan Phillip , Trainer Peter , Keevil Brian

: In community-dwelling men, salivary testosterone (Sal-T) concentrations are thought to represent tissue hormone levels and correlate strongly with serum free-T levels. Measurement of salivary glucocorticoid concentrations is a non-invasive and objective means of assessing cortisol exposure in users and non-users of hydrocortisone therapy. We assessed relationships of Sal-T with transdermal testosterone replacement therapy (TD-TRT) and with markers of testosterone exposure. I...

ea0038fp9 | (1) | SFEBES2015

How well can we measure oestradiol?

Owen Laura , Monaghan Phillip , Armstrong Annie , Keevil Brian

Traditionally, oestradiol measurement is performed by immunoassay. The sensitivity of these assays is not sufficiently sensitive for certain patient groups such as males, post-menopausal females and children. There is also a potential for interference from structurally related compounds or heterophilic antibodies. LC–MS/MS is an attractive alternative as it has increased sensitivity and specificity.We reviewed the requests for LC–MS/MS analysis...

ea0050p187 | Clinical Biochemistry | SFEBES2017

How well can we measure SHBG?

Adaway Jo , Miller Ann Marie , Monaghan Phillip , Merrett Nicola , Keevil Brian , Owen Laura

Sex hormone binding globulin (SHBG) is a glycoprotein which binds hormones such as testosterone. Around 97% of circulating testosterone is bound to SHBG and is therefore biologically unavailable; approximately 2–3% of testosterone is free or loosely bound to proteins such as albumin, and is biologically active, or bioavailable. Free testosterone is very technically challenging to quantify; in order to circumvent this problem, equations are used...

ea0050p187 | Clinical Biochemistry | SFEBES2017

How well can we measure SHBG?

Adaway Jo , Miller Ann Marie , Monaghan Phillip , Merrett Nicola , Keevil Brian , Owen Laura

Sex hormone binding globulin (SHBG) is a glycoprotein which binds hormones such as testosterone. Around 97% of circulating testosterone is bound to SHBG and is therefore biologically unavailable; approximately 2–3% of testosterone is free or loosely bound to proteins such as albumin, and is biologically active, or bioavailable. Free testosterone is very technically challenging to quantify; in order to circumvent this problem, equations are used...

ea0069p27 | Poster Presentations | SFENCC2020

The normalisation of a serum testosterone using GnRH analogue therapy in a case of a single testosterone-secreting adrenal adenoma confirmed on adrenal vein sampling

Riley David , Alforei Elena , Adeyoju Adebanji , Monaghan Phillip , Adam Safwaan , Trainer Peter

Case History: A 53 year old woman presented with a 12-month history of progressive hirsutism and deepening of her voice. Her symptoms coincided with the onset of the menopause. On clinical examination she had evidence of virilisation with muscle hypertrophy.Investigations: Biochemical tests revealed a serum testosterone (serT) of 30 nmol/l, a DHEA-Sulphate of 1.5 umol/l (1.0–12.0), an androstenedione of 3.2 nmol/l (0.0–6.0), a post-overnight de...

ea0065p6 | Adrenal and Cardiovascular | SFEBES2019

Monitoring metyrapone therapy for Cushing’s syndrome using salivary glucocorticoid measurement by liquid chromatography tandem mass spectrometry (LC–MS/MS)

Manson Megan , Adam Safwaan , Higham Claire , Keevil Brian , Trainer Peter , Monaghan Phillip

Introduction: Late-night salivary cortisol assessment is an important element when investigating suspected Cushing’s syndrome (CS). The goal of medical therapy is achieving a mean (of 5 samples during a single day) serum cortisol (serumF) of 150–300 nmol/l (Cushing Day Curve [CDC]). Metyrapone is an 11β-hydroxylase inhibitor elevating levels of 11-deoxycortisol causing conventional immunoassay (IA) to overestimate SerumF; a problem obviated by LC–MS/MS. We ...

ea0038p24 | Clinical biochemistry | SFEBES2015

Serum cortisol: what is your laboratory measuring?

Hawley James , Owen Laura , Monaghan Phillip , Armston Annie , Chadwick Carrie , Keevil Brian

Background: Accurate measurement of serum cortisol is essential in the investigation of the HPA axis. It has been documented that routine immunoassays are liable to both under- and over-recovery leading to inaccurate results and subsequent inappropriate investigations. This study seeks to provide an up-to-date assessment of the accuracy of the major immunoassay platforms and compares results to a liquid chromatography–tandem mass spectrometry (LC–MS/MS) candidate ref...

ea0037ep298 | Calcium and Vitamin D metabolism | ECE2015

Renal calcification in hypoparathyroid patients treated with calcium and vitamin D: can biochemistry help?

Pathmanathan Sivatharshya , Tolhurst Scott , Illingworth Emma , Higham Claire , Trainer Peter , Monaghan Phillip

Introduction: Hypoparathyroidism is most commonly observed following neck surgery and is characterized biochemically by deficient parathyroid hormone (PTH) and hypocalcaemia alongside hyperphosphataemia and reduced 1,25-dihydroxyvitamin D. Standard treatment with oral calcium and vitamin D aims to maintain serum calcium within the low-normal range whilst avoiding hypercalciuria due to over replacement. However, concerns remain over the presence of hypercalciuria and the associ...

ea0031p48 | Clinical biochemistry | SFEBES2013

A comparison of serum chromogranin A measurement with 24 h urine and serum 5-hydroxyindole acetic acid measurement in patients with NETs

Monaghan Phillip , Adaway Joanne , Valle Juan , Hubner Richard , Trainer Peter , Darby Denise , Keevil Brian

Introduction: Chromogranin-A (CgA) is a 49 kDa protein of the granin/secretogranin family originating from dense-core secretory granules within cells of the diffuse endocrine system. CgA is currently the best available diagnostic biomarker for neuroendocrine tumours (NETs) with recent clinical guidelines advocating the measurement of CgA as part of the baseline biochemical profile in patients presenting with symptoms suspicious of a gastroenteropancreatic NET.<p class="abs...

ea0025p36 | Clinical biochemistry | SFEBES2011

Comparison of serum cortisol measurement by immunoassay and liquid chromatography–tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone

Monaghan Phillip , Owen Laura , Trainer Peter , Brabant Georg , Keevil Brian , Darby Denise

The accurate measurement of cortisol by immunoassay is compromised by the potential for cross-reactivity of reagent antibodies with structurally-related steroid compounds present in patient serum. This susceptibility is potentiated when normal steroid metabolism is altered pharmacologically by anti-steroidogenic drugs. This class of drug is utilised in the management of Cushing’s syndrome to moderate cortisol production. To investigate the effect of the 11β-hydroxyla...